| _version_ |
1860797565266558976
|
| building |
INTELEK Repository
|
| collection |
Online Access
|
| collectionurl |
https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072
|
| date |
2016-10-19 15:08:06
|
| format |
Restricted Document
|
| id |
13265
|
| institution |
UniSZA
|
| internalnotes |
J.T. Hickok et al. 5-Hydroxy tryptamine receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial Lancet Oncol (2005) J.L. Geiger The essential oil of ginger, Zingiber officinale and anaesthesia Inter J Aromather (2005) E. Ernst et al. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials Br J Anaesth (2000) W. Steflitsch et al. Clinical aromatherapy J Mens Health (2008) V. Brown et al. The development of the Chemotherapy Symptom Assessment Scale (C-SAS): a scale for the routine clinical assessment of the symptom experiences of patients Inter J Nurs Stud (2001) L. Cohen et al. Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings Support Care Cancer (2007) S.M. Grunberg et al. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics Cancer (2004) L. Bourdeanu et al. Chemotherapy-induced nausea and vomiting in Asian women with breast cancer receiving anthracycline-based adjuvant chemotherapy J Support Oncol (2012) F. Roila et al. Delayed emesis: moderately emetogenic chemotherapy Support Care Cancer (2005) C.M. Bender et al. Chemotherapy-induced nausea and vomiting Clin J Oncol Nurs (2002) B. Bloechl-Daum et al. Delayed nausea and vomiting continue to reduce patients’ quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment J Clin Oncol (2006) S. Price et al. Aromatherapy for health professionals (2007) J. Stringer et al. Aromasticks in cancer care: an innovation not to be sniffed at Complement Ther Clin Pract (2010) P.L. Lua et al. A brief review of current scientific evidence involving aromatherapy use for nausea and vomiting J Altern Complement Med (2012) B. White Ginger: an overview Am Fam Physician (2007)
|
| originalfilename |
7580-01-FH02-FESP-16-06877.jpg
|
| person |
norman
|
| recordtype |
oai_dc
|
| resourceurl |
https://intelek.unisza.edu.my/intelek/pages/view.php?ref=13265
|
| spelling |
13265 https://intelek.unisza.edu.my/intelek/pages/view.php?ref=13265 https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072 Restricted Document Article Journal image/jpeg inches 96 96 norman 1421 27 27 736 2016-10-19 15:08:06 1421x736 7580-01-FH02-FESP-16-06877.jpg UniSZA Private Access The effectiveness of inhaled ginger essential oil in improving dietary intake in breast-cancer patients experiencing chemotherapy-induced nausea and vomiting Focus on Alternative and Complementary Therapies Background Evidence suggests the use of complementary therapies may help in relieving the adverse effects of cancer-related treatment, including nausea. Objectives To evaluate the effectiveness of inhaled ginger essential oil (EO) in improving dietary intake in women with breast cancer experiencing chemotherapy-induced nausea and vomiting (CINV). General perception on the use of ginger aromatherapy was also evaluated. Methods A single-blind, randomised, placebo-controlled, crossover study was conducted in two oncology clinics in Peninsular Malaysia. Women received 5 days of aromatherapy treatment using either ginger EO or fragrance-matched placebo [ginger fragrance oil (FO)] in an order dictated by the treatment group sequence. The following aspects were evaluated: nutritional status (BMI, nutritional requirement, dietary intake) and general perception of aromatherapy. Results Sixty women completed the study (age=47.3±9.26 years; receiving highly emetogenic chemotherapy=86.7%; BMI=25.5±5.4 kg/m2). Energy intakes were significantly higher after patients were treated with ginger EO than ginger FO at day 3 (P=0.015) and day 5 (P=0.002). Significant improvements in energy intake were also observed over time [F(2,57)=54.21, P<0.001], reaching almost 90% of the energy requirement 5 days’ post-chemotherapy. Inhaled aromatherapy using ginger EO was rated marginally more helpful than the ginger FO (63.3% vs. 61.6%). Being delivered via a necklace, the treatment method was considered feasible for participating women. Conclusion The use of inhaled ginger EO for CINV could possibly help patients resume their dietary intake. This complementary treatment was also favourably received by the participating women. 21 1 8-16 J.T. Hickok et al. 5-Hydroxy tryptamine receptor antagonists versus prochlorperazine for control of delayed nausea caused by doxorubicin: a URCC CCOP randomised controlled trial Lancet Oncol (2005) J.L. Geiger The essential oil of ginger, Zingiber officinale and anaesthesia Inter J Aromather (2005) E. Ernst et al. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials Br J Anaesth (2000) W. Steflitsch et al. Clinical aromatherapy J Mens Health (2008) V. Brown et al. The development of the Chemotherapy Symptom Assessment Scale (C-SAS): a scale for the routine clinical assessment of the symptom experiences of patients Inter J Nurs Stud (2001) L. Cohen et al. Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings Support Care Cancer (2007) S.M. Grunberg et al. Incidence of chemotherapy-induced nausea and emesis after modern antiemetics Cancer (2004) L. Bourdeanu et al. Chemotherapy-induced nausea and vomiting in Asian women with breast cancer receiving anthracycline-based adjuvant chemotherapy J Support Oncol (2012) F. Roila et al. Delayed emesis: moderately emetogenic chemotherapy Support Care Cancer (2005) C.M. Bender et al. Chemotherapy-induced nausea and vomiting Clin J Oncol Nurs (2002) B. Bloechl-Daum et al. Delayed nausea and vomiting continue to reduce patients’ quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment J Clin Oncol (2006) S. Price et al. Aromatherapy for health professionals (2007) J. Stringer et al. Aromasticks in cancer care: an innovation not to be sniffed at Complement Ther Clin Pract (2010) P.L. Lua et al. A brief review of current scientific evidence involving aromatherapy use for nausea and vomiting J Altern Complement Med (2012) B. White Ginger: an overview Am Fam Physician (2007)
|
| spellingShingle |
The effectiveness of inhaled ginger essential oil in improving dietary intake in breast-cancer patients experiencing chemotherapy-induced nausea and vomiting
|
| summary |
Background Evidence suggests the use of complementary therapies may help in relieving the adverse effects of cancer-related treatment, including nausea. Objectives To evaluate the effectiveness of inhaled ginger essential oil (EO) in improving dietary intake in women with breast cancer experiencing chemotherapy-induced nausea and vomiting (CINV). General perception on the use of ginger aromatherapy was also evaluated. Methods A single-blind, randomised, placebo-controlled, crossover study was conducted in two oncology clinics in Peninsular Malaysia. Women received 5 days of aromatherapy treatment using either ginger EO or fragrance-matched placebo [ginger fragrance oil (FO)] in an order dictated by the treatment group sequence. The following aspects were evaluated: nutritional status (BMI, nutritional requirement, dietary intake) and general perception of aromatherapy. Results Sixty women completed the study (age=47.3±9.26 years; receiving highly emetogenic chemotherapy=86.7%; BMI=25.5±5.4 kg/m2). Energy intakes were significantly higher after patients were treated with ginger EO than ginger FO at day 3 (P=0.015) and day 5 (P=0.002). Significant improvements in energy intake were also observed over time [F(2,57)=54.21, P<0.001], reaching almost 90% of the energy requirement 5 days’ post-chemotherapy. Inhaled aromatherapy using ginger EO was rated marginally more helpful than the ginger FO (63.3% vs. 61.6%). Being delivered via a necklace, the treatment method was considered feasible for participating women. Conclusion The use of inhaled ginger EO for CINV could possibly help patients resume their dietary intake. This complementary treatment was also favourably received by the participating women.
|
| title |
The effectiveness of inhaled ginger essential oil in improving dietary intake in breast-cancer patients experiencing chemotherapy-induced nausea and vomiting
|
| title_full |
The effectiveness of inhaled ginger essential oil in improving dietary intake in breast-cancer patients experiencing chemotherapy-induced nausea and vomiting
|
| title_fullStr |
The effectiveness of inhaled ginger essential oil in improving dietary intake in breast-cancer patients experiencing chemotherapy-induced nausea and vomiting
|
| title_full_unstemmed |
The effectiveness of inhaled ginger essential oil in improving dietary intake in breast-cancer patients experiencing chemotherapy-induced nausea and vomiting
|
| title_short |
The effectiveness of inhaled ginger essential oil in improving dietary intake in breast-cancer patients experiencing chemotherapy-induced nausea and vomiting
|
| title_sort |
effectiveness of inhaled ginger essential oil in improving dietary intake in breast-cancer patients experiencing chemotherapy-induced nausea and vomiting
|